U.S. Paper and Forestry Products Stock News

MBIA (MBI) continues to operate at a loss, but over the last five years the company has narrowed those losses at an average annual rate of 3.2%. Despite this gradual progress, MBIA’s net profit margin is still in negative territory, and its valuation stands out. The Price-to-Sales Ratio sits at 3.5x, which is significantly higher than both the US insurance industry average of 1.1x and a peer group average of 1.3x. With profitability still out of reach and no fair value estimate available,...

Upstart Holdings (UPST) is forecast to grow earnings by 56.05% per year and increase revenue at an annual rate of 18.8%, outpacing the broader US market’s 10.5% growth projection. Despite the strong outlook, the company remains unprofitable, with losses having accelerated at 43.8% annually over the past five years. Investors will note the current Price-to-Sales ratio of 4.6x sits above industry and peer averages. With shares trading at $41.75, below analysts’ fair value estimate of $47.40,...

CeriBell (CBLL) is forecast to grow revenue by 23.39% per year, outpacing the US market’s projected 10.5% annual increase. Despite this trajectory, the company remains unprofitable and is not expected to reach profitability within the next three years, with no evidence of net profit margin improvement over the last twelve months. Investors are likely to weigh CeriBell's robust top-line expansion against continued losses and a valuation multiple well above peers. See our full analysis for...

Stoke Therapeutics (STOK) has moved into profitability over the past year and is now forecasting revenue growth of 20.1% per year, which handily outpaces the broader US market's 10.5% annual growth expectation. However, earnings are projected to decline by 5.6% each year over the next three years, suggesting the company's recently achieved profit status may be tested as the bottom line comes under pressure. The premium valuation and mixed outlook put investor attention squarely on how...

Arista Networks (ANET) posted net profit margins of 40.9%, up from 39% last year, and delivered a strong 32.1% earnings growth over the past year. Earnings are expected to grow 16.31% annually, with revenue projected to rise 16.6% per year. Both figures comfortably outpace the broader US market's revenue outlook of 10.5%. With five-year annualized earnings growth at 35.5%, investors will be weighing these rapid gains against a recent share price of $140.42, which is notably above the...

Corsair Gaming (CRSR) reported that losses have deepened at an average rate of 68.9% per year over the past five years, reflecting mounting unprofitability even as the company forecasts 8.7% annual revenue growth, which is below the 10.5% US market average. However, with earnings expected to grow at a robust 96.57% per year and profitability projected within the next three years, Corsair is seen by some investors as a turnaround candidate. See our full analysis for Corsair Gaming. Next up, we...

Solid Power (SLDP) continues to operate at a loss, with net losses deepening at a 50.3% annual rate over the last five years. Despite persistent negative profit margins, analysts forecast revenue growth of 40.5% per year, far outpacing the US market’s 10.5% average and SLDP’s peer group. This high growth outlook is very much in focus as investors weigh it against ongoing losses and a valuation that already sits far above sector averages. See our full analysis for Solid Power. Next, we’ll see...

Astera Labs (ALAB) has just turned profitable, with forecasts calling for earnings to grow at 27.1% per year and revenue to rise 23.5% annually, both comfortably ahead of US market averages. The company’s net profit margin has flipped from negative to positive, and its high quality earnings profile comes as shares are trading at a remarkable premium: a Price-To-Sales ratio of 49.9x, well above both direct semiconductor peers and the industry average. With no major risks or insider selling...

Andersons (ANDE) grew its earnings at an average annual rate of 16.2% over the past five years, recently posting a net profit margin of 0.7% compared to last year's 0.8%. Despite these longer-term gains, the company recorded negative earnings growth for the past year, creating a notable contrast with its historical trajectory. Investors are weighing the company’s profitable track record, slight margin compression, and the possibility that shares trading at $48.48, well below the estimated...

AnaptysBio (ANAB) is forecasting revenue growth of 25.9% per year, ahead of the broader US market’s 10.5% growth rate. Despite this, the company remains unprofitable, with losses climbing at an annual pace of 29.9% over the past five years. Net profit margins and earnings quality have yet to show improvement. Shares currently trade at a Price-to-Sales ratio of 8.2x, which offers better value than the US Biotech sector average of 10.3x, but appears expensive relative to peers at 5.8x. This...

Perdoceo Education (PRDO) posted annual earnings growth of 13.3%, which pushed its five-year average to 6.2% per year. This signals an acceleration in profit expansion. The company’s net profit margin currently sits at 20.1%, down slightly from 20.6% last year. Its Price-To-Earnings ratio of 12.7x is noticeably lower than both its peer group and the broader US Consumer Services industry. With a robust margin profile and a valuation discount to peers, Perdoceo’s financial results offer plenty...

Global Medical REIT (GMRE) has posted a turnaround, moving into profitability as net profit margins improved and earnings climbed by an average of 16.9% per year over the past five years. Looking ahead, earnings are forecast to accelerate by 22.6% per year, outpacing the broader US market's expected 16% growth. However, projected revenue growth of 2.9% per year lags market averages. A one-off gain of $6.8 million played a notable role in the latest results, so investors will want to keep an...

Summit Hotel Properties (INN) remains unprofitable, with net profit margins showing no improvement over the last year. Despite the lack of accelerated profit growth, the company has reduced its losses over the past five years at a steady annual rate of 66.5%. Revenue is forecast to rise by 2.1% each year, which trails well behind the broader US market’s 10.5% pace. For value-focused investors, shares trading at $5.27, well below the estimated fair value of $17.75, create an intriguing setup...

Limbach Holdings (LMB) posted net profit margins of 6.4%, improving from 5.1% last year, as annual earnings jumped 35.8%. The company’s five-year average annual earnings growth came in at 47.4%, with revenue forecast to grow 11.3% per year and annual earnings expected to rise 19.2% per year, both outpacing the broader US market. Investors are likely to see higher profitability, rapid growth, and a price-to-earnings ratio below industry peers as a favorable setup for the current valuation...

Rigel Pharmaceuticals (RIGL) has turned profitable in the last year, with net profits reversing after a string of losses. The company’s earnings grew at an impressive 40.2% per year over the past five years, signaling high quality performance. However, forward guidance calls for a 4% annual decline in earnings over the next three years and revenue growth of just 6.5% per year, falling short of the US market’s 10.5% average. Despite upbeat profit growth, the outlook now turns on whether Rigel...

Mosaic (MOS) delivered remarkable earnings growth of 284% over the last year, a sharp turnaround from its five-year average decline of -8.4% per year. Net profit margins strengthened significantly, moving from 2% to 8.4%. However, this surge was driven in part by a one-off $652.2 million gain, making some of these earnings non-recurring. Looking ahead, sentiment will weigh Mosaic’s low Price-to-Earnings Ratio of 8.9x and pricing below analyst fair value estimates against the forecast for...

Best Buy is making moves to stand out in the retail landscape with fresh partnerships and experiential store formats. The recent rollout of IKEA shop-in-shops and new tech offerings signals a clear shift in strategy for customer engagement. See our latest analysis for Best Buy. After a slow start to the year, Best Buy's share price has picked up steam recently, climbing nearly 20% over the past 90 days to $80.88. While momentum is building in the short term, the one-year total shareholder...

Postal Realty Trust (PSTL) delivered a net profit margin of 10.4%, a substantial leap from last year’s 2.7%, as robust earnings fueled a 377.6% jump in growth over the past year. The company has built a five-year track record of consistent profitability gains and, looking forward, earnings are projected to grow at roughly 10% annually with revenue forecast to rise 11.5% per year, ahead of the general US market. Investors are weighing these strong margin improvements and sustained profit...

Latham Group (SWIM) is currently unprofitable, with expectations to turn profitable within the next three years. Earnings are forecast to grow quickly at 46.36% per year, significantly outpacing the broader market. Revenue is projected to rise by 4.8% per year, which is a much slower pace than the US market's 10.5%. The company has steadily reduced its losses by an annual rate of 13.7% over the past five years. While the Price-to-Sales Ratio sits well above industry peers at 1.6x, shares are...

Axon Enterprise (AXON) posted eye-catching forecasts, with revenue expected to grow 21.6% annually, significantly outpacing the broader US market’s 10.5% rate. EPS is also projected to rise sharply by 55.2% per year. However, the company’s net profit margin slipped to 13.6% from 16.2% last year, and its most recent annual earnings growth of 11.3% is below its five-year average of 59.9%. The results also include a sizable one-off gain of $197.6 million, which complicates the assessment of the...

Navitas Semiconductor (NVTS) is forecasting standout growth, with revenue expected to rise 26.6% per year. This is more than double the broader US market’s 10.5% annual pace. Despite that top-line momentum, the company remains unprofitable, with losses having deepened at a rate of 22.5% per year over the past five years and no signs yet of margins improving. Investors now face the lure of rapid revenue growth, weighed against persistent unprofitability and the stock’s hefty valuation premium...

Carnival Corporation (NYSE:CCL) is back in the spotlight as the Carnival Horizon delivered critical aid to Jamaica following Hurricane Melissa. The cruise line, together with partners, pledged $1 million to Direct Relief to help the region recover. See our latest analysis for Carnival Corporation &. Carnival Corporation’s recent relief efforts in Jamaica arrive on the heels of a strong year for the company, with investor sentiment generally buoyant despite a few bumps. While the share price...

Finance of America Companies (FOA) recently returned to profitability, with net profit margins improving over the past year. However, earnings for the last twelve months were notably impacted by a one-off gain of $54.9 million that does not represent regular operational income. Over the past five years, FOA’s earnings have declined by an average of 15.6% per year. Revenue is forecast to grow at 8.6% annually, which trails the broader US market’s projected 10.5% pace. See our full analysis for...

Teladoc Health (TDOC) has been on the radar of investors lately after recent price fluctuations, with the stock showing some movement over the past month. It is a name many are re-evaluating in light of shifting healthcare trends. See our latest analysis for Teladoc Health. After a rocky start to the year, Teladoc Health's share price has rebounded with a strong 16% gain over the past 90 days. However, the longer-term picture remains challenging, as the one-year total shareholder return is...